Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Kenji Izuhara
Macrophages are essential to the immunological responses associated with atherosclerosis. Recent research on the role of macrophage autophagy (AP) in the development of atherosclerosis has shown a brand-new mechanism by which these cells contribute to vascular inflammation. The transport of cytoplasmic contents to the lysosomal apparatus during AP is a cellular catabolic process that will ultimately result in destruction and recycling. In the early stages of atherosclerosis, basal levels of macrophage AP are crucial for atheroprotection. However, AP deficiency promotes vascular inflammation, oxidative stress, and plaque necrosis in the latter phases of the pathophysiology when it becomes dysfunctional. In this essay, we’ll talk about the involvement of macrophages and AP in atherosclerosis and the growing body of research proving that macrophage AP contributes to vascular disease. We will finally talk on how AP might be targeted for therapeutic utility.